Found: 85
Select item for more details and to access through your institution.
Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 3, p. 241, doi. 10.1007/s10637-005-6732-1
- By:
- Publication type:
- Article
Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197146
- By:
- Publication type:
- Article
Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2343278, doi. 10.1001/jamanetworkopen.2023.43278
- By:
- Publication type:
- Article
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 9, p. e2335813, doi. 10.1001/jamanetworkopen.2023.35813
- By:
- Publication type:
- Article
Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
- Published in:
- Nature Communications, 2016, v. 7, n. 11, p. 13513, doi. 10.1038/ncomms13513
- By:
- Publication type:
- Article
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
- Published in:
- Nature Communications, 2016, v. 7, n. 6, p. 11815, doi. 10.1038/ncomms11815
- By:
- Publication type:
- Article
Review of erlotinib in the treatment of advanced non-small cell lung cancer.
- Published in:
- Biologics: Targets & Therapy, 2007, v. 1, n. 4, p. 335
- By:
- Publication type:
- Article
Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?
- Published in:
- Current Atherosclerosis Reports, 2016, v. 18, n. 12, p. 1, doi. 10.1007/s11883-016-0625-y
- By:
- Publication type:
- Article
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 1, p. 233, doi. 10.1007/s11060-022-04145-x
- By:
- Publication type:
- Article
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 1, p. 125, doi. 10.1007/s11060-020-03686-3
- By:
- Publication type:
- Article
Lung Cancer Among Postmenopausal Women Treated With Estrogen Alone in the Women's Health Initiative Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 18, p. 1413, doi. 10.1093/jnci/djq285
- By:
- Publication type:
- Article
Lung Cancer Incidence in Never Smokers.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 2, p. 49
- By:
- Publication type:
- Article
A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution.
- Published in:
- Lung India, 2022, v. 39, n. 4, p. 315, doi. 10.4103/lungindia.lungindia_428_21
- By:
- Publication type:
- Article
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 102, doi. 10.1159/000500571
- By:
- Publication type:
- Article
The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Novel Treatments for Thymoma and Thymic Carcinoma.
- Published in:
- Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2015.00267
- By:
- Publication type:
- Article
Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor.
- Published in:
- BioDrugs, 2009, v. 23, n. 5, p. 289, doi. 10.2165/11317600-000000000-00000
- By:
- Publication type:
- Article
Integrated digital error suppression for improved detection of circulating tumor DNA.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 5, p. 547, doi. 10.1038/nbt.3520
- By:
- Publication type:
- Article
Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer.
- Published in:
- Journal of Patient-Reported Outcomes, 2021, v. 5, n. 1, p. 1, doi. 10.1186/s41687-021-00358-2
- By:
- Publication type:
- Article
A Review of Immunotherapy for Stage III and Metastatic Non‐Small Cell Lung Cancer and the Rationale for the ECOG‐ACRIN EA5181 Study.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 523, doi. 10.1002/onco.13725
- By:
- Publication type:
- Article
Osimertinib for EGFR‐Mutant Lung Cancer with Brain Metastases: Results from a Single‐Center Retrospective Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 836, doi. 10.1634/theoncologist.2018-0264
- By:
- Publication type:
- Article
Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 786, doi. 10.1634/theoncologist.2016-0458
- By:
- Publication type:
- Article
Optimal Adjuvant Therapy for Non-Small Cell Lung Cancer--How to Handle Stage I Disease.
- Published in:
- Oncologist, 2007, v. 12, n. 3, p. 331, doi. 10.1634/theoncologist.12-3-331
- By:
- Publication type:
- Article
EGFR exon 20 Insertion NSCLC and Response to Platinum-Based Chemotherapy.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. e148, doi. 10.1016/j.cllc.2021.07.001
- By:
- Publication type:
- Article
Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e673, doi. 10.1016/j.cllc.2020.12.005
- By:
- Publication type:
- Article
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 201, doi. 10.1016/j.cllc.2021.01.010
- By:
- Publication type:
- Article
PD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature Review.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. e329, doi. 10.1016/j.cllc.2020.05.012
- By:
- Publication type:
- Article
Two Cases of Pulmonary Tumor Thrombotic Microangiopathy Associated with ROS1-Rearranged Non-Small-Cell Lung Cancer.
- Published in:
- 2021
- By:
- Publication type:
- case study
Opportunistic Invasive Fungal Infections Mimicking Progression of Non-Small-Cell Lung Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Increased Galectin-1 Expression in Thymic Epithelial Tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population‐based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 4, p. 1211, doi. 10.1002/cam4.1430
- By:
- Publication type:
- Article
Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1139940
- By:
- Publication type:
- Article
Top advances of the year: Perioperative therapy for lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 17, p. 2897, doi. 10.1002/cncr.35357
- By:
- Publication type:
- Article
Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 770, doi. 10.1002/cncr.35069
- By:
- Publication type:
- Article
Differences in Active and Passive Smoking Exposures and Lung Cancer Incidence Between Veterans and Non-Veterans in the Women's Health Initiative.
- Published in:
- Gerontologist, 2016, v. 56, p. S102, doi. 10.1093/geront/gnv664
- By:
- Publication type:
- Article
Chemotherapy Definitions and Policies for Thymic Malignancies.
- Published in:
- Chinese Journal of Lung Cancer, 2014, v. 17, n. 2, p. 116, doi. 10.3779/j.issn.1009-3419.2014.02.09
- By:
- Publication type:
- Article
Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies.
- Published in:
- Neuro-Oncology Advances, 2021, v. 3, p. v52, doi. 10.1093/noajnl/vdab106
- By:
- Publication type:
- Article
Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy.
- Published in:
- Journal of Cutaneous Pathology, 2016, v. 43, n. 4, p. 339, doi. 10.1111/cup.12666
- By:
- Publication type:
- Article
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 3, p. 534, doi. 10.1093/clinchem/hvaa307
- By:
- Publication type:
- Article
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 3, p. 1, doi. 10.1093/jncics/pkac033
- By:
- Publication type:
- Article